Kirsten Remmert, PhD

Staff Scientist
National Cancer Institute | National Institutes of Health, United States

Presentation(s):

• 40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma

  Thursday, March 23, 2023
  10:46 AM – 10:56 AM

  Disclosure information not submitted.

• P51: Hyperthermic intraperitoneal chemotherapy restores physiologic tumor stiffness & stimulates lymphocyte proliferation & recruitment

  Friday, March 24, 2023
  6:21 PM – 6:27 PM

  Disclosure information not submitted.